Koshinski Asset Management
CLVS

Koshinski Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Koshinski Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,600
Closed -$33.9K – 2279
2021
Q3 		$33.9K Buy
+7,600
New +$36.6K ﹤0.01% 1264
2021
Q1 		– Sell
-11,250
Closed -$54K – 649
2020
Q4 		$54K Sell
11,250
-1,300
-10% -$6.58K 0.01% 538
2020
Q3 		$70 Hold
12,550
– – 0.01% 505
2020
Q2 		$85K Buy
12,550
+450
+4% +$3.41K 0.01% 481
2020
Q1 		$77K Sell
12,100
-200
-2% -$1.6K 0.02% 447
2019
Q4 		$125K Buy
+12,300
New +$89.4K 0.02% 497

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Koshinski Asset Management's CLVS Position: Q4 2021 in Review

Koshinski Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 7,600 shares — an estimated $33.9K sold.

Koshinski Asset Management first reported a position in CLVS in Q4 2019 and held it in 6 quarters. The position peaked at $125K in Q4 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Koshinski Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Koshinski Asset Management sold 7,600 Clovis Oncology, Inc. shares in Q4 2021, an estimated $33.9K.
  • Koshinski Asset Management first reported a position in Clovis Oncology, Inc. in Q4 2019 and held it in 6 quarters.
  • Koshinski Asset Management's Clovis Oncology, Inc. position peaked at $125K in Q4 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Koshinski Asset Management's 13F filing for Q4 2021, filed 14 Jan 2022.